Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date? Lidia GattoVincenzo Di NunnoAlba Ariela Brandes Leading Article 09 April 2022 Pages: 491 - 510
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome Thomas J. P. MangnusKrishna D. BharwaniFrank J. P. M. Huygen Review Article Open access 05 March 2022 Pages: 511 - 531
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria George G. ZhanelMarianna PozdircaJames A. Karlowsky Review Article 16 March 2022 Pages: 533 - 557
Contemporary Management of Dyslipidemia Richard A. FerraroThorsten LeuckerPeter P. Toth Review Article 18 March 2022 Pages: 559 - 576
Aumolertinib: A Review in Non-Small Cell Lung Cancer Matt ShirleySusan J. Keam Adis Drug Evaluation 19 March 2022 Pages: 577 - 584
Nirmatrelvir Plus Ritonavir: First Approval Yvette N. Lamb AdisInsight Report Open access 19 March 2022 Pages: 585 - 591
Sugemalimab: First Approval Sohita DhillonSean Duggan AdisInsight Report 17 March 2022 Pages: 593 - 599
Daridorexant: First Approval Anthony Markham AdisInsight Report Open access 17 March 2022 Pages: 601 - 607
Correction to: Abrocitinib: First Approval Emma D. DeeksSean Duggan Correction Open access 11 March 2022 Pages: 609 - 609
Correction to: Efgartigimod: First Approval Young-A Heo Correction Open access 30 March 2022 Pages: 611 - 611